Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026)

Ascendis Pharma A (ASND) has 15 years of Non-Current Assets data on file, last reported at $1.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 139571.36% year-over-year to $1.0 billion; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 49937.26% YoY), and the FY2025 full-year result was $225.3 million, up 78.99% from the prior year.
• Non-Current Assets rose to $1.0 billion in Q1 2026, from -$3.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.0 billion in Q1 2026 to a low of -$3.9 million in Q4 2025.
• A 5-year average of $164.1 million and a median of $152.7 million in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets sank 864.46% in 2025 and surged 139571.36% in 2026, its largest moves.
• Tracing ASND's Non-Current Assets over 5 years: stood at $136.6 million in 2022, then declined by 9.4% to $123.8 million in 2023, then plunged by 100.33% to -$409272.0 in 2024, then slumped by 864.46% to -$3.9 million in 2025, then soared by 26228.31% to $1.0 billion in 2026.
• Business Quant data shows ASND's Non-Current Assets at $1.0 billion in Q1 2026, -$3.9 million in Q4 2025, and $160.1 million in Q3 2025.